Skip to main content
Caplight Logo









NeuroIntact, Inc.

NeuroIntact, Inc.

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://neurointact.com/

Last Round

Seed

Dec 11, 2025

Total Funding Raised

$7.15M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

NeuroIntact, Inc. is a medical device company that develops non-invasive targeted temperature management systems to preserve neurological function in patients with brain injuries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Defense Tech

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

targeted temperature managementTTMintranasal coolingneuroprotectionmedical devicebrain coolingneurocritical carecombat casualty caretrauma caredefense techtherapeutic hypothermiaportable medical devicenon-invasive coolingclinical researchmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuroIntact, Inc. Comparables

Compare NeuroIntact, Inc. with similar companies based on industry and business-model similarity.

NeuroIntact, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CoolTech Medical
90%
Cryothermic Systems
79%
Neuron Guard
79%

NeuroIntact, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 11, 2025
SeedOct 31, 2024
GrantSep 13, 2024

NeuroIntact, Inc. Investors

Notable investors and investment history

NeuroIntact, Inc. investors
InvestorRounds
TEDCOSeed
Central Texas Angel NetworkSeed
Riptide VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 11, 2025

    $6M round led by Riptide Ventures.

  • Oct 31, 2024

    $250K raised with TEDCO as an investor.

NeuroIntact, Inc. Filings

Explore SEC and related filing metadata, where available.

NeuroIntact, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NeuroIntact, Inc.'s valuation, stock price, and market status.

Is NeuroIntact, Inc. a public or private company?

NeuroIntact, Inc. is a private company.

What is the current stock price of NeuroIntact, Inc.?

NeuroIntact, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is NeuroIntact, Inc. worth (valuation)?

Valuation information for NeuroIntact, Inc. is not publicly available.

Can I buy NeuroIntact, Inc. stock?

NeuroIntact, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NeuroIntact, Inc.'s last funding round?

NeuroIntact, Inc.'s most recent funding round was Seed on December 11, 2025.

Who are the main investors in NeuroIntact, Inc.?

Key investors in NeuroIntact, Inc. include TEDCO, Central Texas Angel Network, Riptide Ventures.

Will NeuroIntact, Inc. IPO soon?

No public IPO plans have been announced for NeuroIntact, Inc..

How can I track NeuroIntact, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuroIntact, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range8
Year Founded2023
Last FundingDec 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?